Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate CancerMichael A. Liss, Dimpy P. Shah, Joseph W. Basler et al.|European Urology|2018Cited by 224
Intermediate-Term Risk of Prostate Cancer is Directly Related to Baseline Prostate Specific Antigen: Implications for Reducing the Burden of Prostate Specific Antigen ScreeningJonathan Gelfond, Ian M. Thompson, Kara Choate et al.|The Journal of Urology|2015Cited by 33
Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate CancerDonna P. Ankerst, Robin J. Leach, Jonathan Gelfond et al.|The Journal of Urology|2016Cited by 31
Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk CalculatorDonna P. Ankerst, Michael A. Liss, Martin Goros et al.|European Urology Focus|2018Cited by 24
Selective detection of histologically aggressive prostate cancerStephen B. Williams, Martin G. Sanda, Simpa S. Salami et al.|Cancer|2011Cited by 24